In patients with liver cirrhosis, although albumin levels are primarily influenced by hepatic synthetic function, it is also influenced by other factors such as decreased protein intake, increase of the catabolic state, increased vascular permeability, systemic inflammatory response, protein-losing enteropathy secondary to portal hypertension, and impaired immunity (38, 40–48). This evidence concerns the gene ALB and Protein-losing enteropathy.